Niche Players Accelerate 2026 Capital Deployment: Equinox Revenue Doubles as iPower Pivots to AI
I'm LongbridgeAI, I can summarize articles.Several mid-cap companies are advancing structural overhauls in 2026. Equinox Gold posted a 103% revenue jump in Q1, while iPower and REalloys locked in fresh capital for AI hardware and rare earth operations.
Companies across specialized sectors are accelerating their strategic realignments in 2026 through divestitures, subsidiary spin-offs, and targeted private placements. Capital flows are increasingly concentrating on projects with immediate revenue visibility, from artificial intelligence infrastructure to domestic mineral extraction, according to data compiled by industry analysts and recent corporate filings. As the macroeconomic environment shifts throughout the year, many of these niche market players are targeting faster operational turnarounds.
Equinox Gold Corp (EQX.US)
Equinox Gold (EQX.US) is up over 30% year-to-date, outperforming broader mining indices. The company reported total revenue of USD 861.6 million for the first quarter of 2026, representing a 103.3% increase year-over-year. According to people familiar with the matter, Equinox has successfully reduced its net debt to USD 252 million following the USD 891 million sale of its Brazilian operations, setting the stage for increased free cash flow as its Greenstone project ramps up.
Cognex Corp (CGNX.US)
Cognex (CGNX.US) has been trading steadily in recent weeks. The machine vision specialist generated USD 268 million in revenue during the first quarter of 2026, up 24% from the previous year. On April 1, 2026, the company finalized the divestiture of its Japan-focused trade business for approximately USD 11.9 million. Management is expected to provide further details on edge AI adoption rates during their upcoming earnings call.
Affirm Holdings Inc (AFRM.US)
Affirm (AFRM.US) is consolidating after recent pullbacks. The financial platform is actively expanding its network footprint, launching its services across all Bed Bath & Beyond brands on July 1, 2026. Concurrent with the expansion, Ryan Schneider joined the board of directors, a move that is expected to bolster the company's credit underwriting strategy.
Recon Technology Ltd (RCON.US)
Recon Technology (RCON.US) is currently navigating compliance hurdles. The Chinese oilfield services integrator received a Nasdaq notification earlier this year regarding its failure to meet the USD 1.00 minimum bid requirement, giving it until November 2 to regain compliance. Despite this, the company reported RMB 85 million in revenue for the first six months of fiscal 2026, up 102.2% year-over-year.
iPower Inc (IPW.US)
iPower (IPW.US) shares have seen an uptick in trading volume. The company is actively pivoting from e-commerce toward AI infrastructure. In July 2026, iPower secured USD 2 million in growth capital and subsequently announced plans to establish an AI subsidiary for hardware leasing, signing a non-binding letter of intent to rent out dedicated high-performance GPU systems to potential clients.
Avantor Inc (AVTR.US)
Avantor (AVTR.US) has tracked the broader life sciences sector closely. The company expanded the partnership between its NuSil brand and the Population Council in July 2026, aiming to develop long-acting disease prevention products. Analysts are waiting for its second-quarter earnings release to gauge global healthcare supply chain margin recoveries.
Elong Power Holding Limited (ELPW.US)
Elong Power (ELPW.US) has moved following recent financing activities. On July 13, 2026, the lithium-ion battery developer closed a USD 6.6 million public offering. The proceeds are targeted to support research and commercialization of high-power battery tech for alternative energy vehicles. The company also adjusted the effective date of its 80-for-1 reverse stock split.
Harrow Inc (HROW.US)
Harrow (HROW.US) has been trending upward. The ophthalmic healthcare company announced the commercial launch of BYOOVIZ in the US on July 1, 2026, and recently presented growing clinical evidence at a major medical annual meeting to support its core portfolio. Management expects its high-value pharmaceutical market share to expand further.
REalloys Inc (ALOY.US)
REalloys (ALOY.US) has secured substantial financial backing this year. The rare earth firm closed a USD 100 million private placement of common stock in June 2026. According to people familiar with the matter, the company previously announced a landmark partnership with the US Army to operate a processing facility in Utah, racing to meet the Department of Defense's 2027 localization deadline for heavy rare earth materials.
LASC (LASC.US)
LASC (LASC.US) has traded with limited volatility this quarter as market participants await further corporate updates. The company is currently evaluating its next strategic initiatives and has not yet released specific capital expenditure targets for 2026. Market observers believe the firm is waiting for clearer industry catalysts to define its long-term positioning.
Looking at the broader competitive landscape, the rapid funding cycles—exemplified by REalloys' USD 100 million placement and iPower's targeted capital raise—indicate that institutional money is actively prioritizing firms building out physical infrastructure. Whether in defense-grade supply chains or AI compute hardware, companies that can translate macroeconomic themes into tangible backlog are poised to capture the bulk of incoming capital.
This article does not constitute investment advice.
